Minaei et al. validated the overexpression of urokinase plasminogen activator receptor (uPAR, encoded by PLAUR) in a larger patient cohort by demonstrating higher uPAR staining intensity in metastatic tumors, supporting its crucial role in promoting metastasis in cSCC and its potential as a therapeutic target. This evidence concerns the gene PLAUR and skin squamous cell carcinoma.